Related Experiment Videos
Testicular hydrocele treated by bismuth phosphate injection
M Dimberg1, H Norlén, L Zachrisson
1Department of Urology, St. Erik's Hospital, Stockholm, Sweden.
International Urology and Nephrology
|January 1, 1988
Summary
Bismuth phosphate injections effectively treated testicular hydroceles in 53% of patients, offering a potential surgical alternative, especially for elderly individuals. Some patients experienced delayed regression or required surgery.
Area of Science:
- Urology
- Minimally Invasive Procedures
Background:
- Testicular hydrocele is a common condition causing scrotal swelling.
- Surgical intervention is the traditional treatment for testicular hydroceles.
- Minimally invasive options are sought to reduce surgical risks and recovery time.
Purpose of the Study:
- To evaluate the efficacy and safety of bismuth phosphate injection for treating testicular hydrocele.
- To determine the rate of complete regression and clinical improvement.
- To assess the potential of this method as an alternative to surgery.
Main Methods:
- Thirty-eight patients with testicular hydrocele were included in the study.
- Treatment involved injection of 0.2-0.4 g of bismuth phosphate.
- Follow-up was conducted on 32 patients to assess outcomes.
Main Results:
- Complete regression of hydrocele was observed in 17 patients (53%), with one case requiring 24 months for full resolution.
- Clinical improvement was noted in 8 patients (25%).
- Six patients (19%) did not respond to treatment and underwent surgery; one patient reported residual scrotal tenderness.
Conclusions:
- Bismuth phosphate injection demonstrates a 53% complete regression rate for testicular hydroceles.
- This injection method may serve as a viable alternative to surgery, particularly for elderly patients.
- Further research could explore optimal dosing and patient selection for this minimally invasive approach.